| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |